Research and analysis

Laboratory reports of hepatitis C infections in England and Wales: October to December 2024

Published 27 February 2025

Applies to England and Wales

Between October and December, a total of 2,626 laboratory reports of hepatitis C (HCV) were reported to UKHSA.

There was a 17% decrease in the number of reports compared to the fourth quarter of 2023 (n=3,153).

Since 2017, one laboratory in the North West of England has undertaken HCV dried blood spot testing alongside hepatitis C routine laboratory testing. This single laboratory has taken on testing for a large part of the country; however, some samples, where geographical information is lacking, may have been incorrectly assigned to this specific laboratory rather than the laboratory from which the sample originated.

Age and sex were well reported (99.8% complete). Where sex was known, males accounted for 69% of reports (1,635out of 2,626), which is higher than previous quarters and years. Adults aged 35 to 44 years accounted for 25% of the total number of hepatitis C reports.

Table 1. Laboratory reports of hepatitis C in England and Wales, October to December 2024*

Age group Males Females Unknown Total
1 to 4 years 1   3   0   4 
5 to 9 years 2   0   0   2 
10 to 14 years 1   0   0   1 
15 to 24 years 48   29   4   81 
25 to 34 years 224   129   7   360 
35 to 44 years 418   234   13   665 
45 to 54 years 384   178   6   568 
55 to 64 years 303   145   5   453 
≥65 years 254   227   6   487 
Unknown 0   0   5   5 
Total 1,635   945    46    2,626

*Provisional data

Notes: Individuals aged under 1 year are excluded, since positive tests in this age group may reflect the presence of passively-acquired maternal antibody rather than true infection. Laboratory reports are not reliable for differentiating acute and chronic hepatitis C infections. Laboratory reports include individuals with a positive test for hepatitis C antibody, antigen and/or detection of hepatitis C RNA. A small proportion of these specimens are diagnosed following dried blood spot (DBS) testing; however, not all DBS testing is reported by laboratories.

In Table 2, laboratory reports are presented broken down by Operational Delivery Network (ODN). ODNs were launched in October 2013 following the publication of the NHS England strategy to sustain and develop clinical networks.

ODNs are the networks through which hepatitis C treatment is being delivered across England. Between October and December 2024, 2,081 out of 3,300 individuals in England had been allocated to an ODN.

Table 2. Laboratory reports of hepatitis C by Operational Delivery Network, October and December 2024*

Primary ODN Total
Barts 186
Birmingham 119
Bristol and Severn 134
Cheshire and Merseyside 73
Eastern Hepatitis Network 75
Greater Manchester and Eastern Cheshire 189
Humberside and North Yorkshire 31
Kent Network via Kings 31
Lancashire and South Cumbria 88
Leicester 62
North Central London 101
North East and Cumbria 106
Nottingham 150
South Thames Hepatitis Network 147
South West Peninsula 45
South Yorkshire 81
Surrey Hepatitis Services 61
Sussex Hepatology Network 49
Thames Valley Hep C ODN 21
Wessex Hep C ODN 66
West London 194
West Yorkshire 71

*Provisional data

ODNs are based on NHS England Clinical Commissioning Groups (CCGs) geographic boundaries. NHS England allocates a primary or lead ODN for CCGs which may cross more than one ODN.